Inventor
HQ HAN
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
C12NMicroorganisms or enzymes18%
PatentTitleYear
12,187,783Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB ligand trap proteins202511,932,677Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases202411,292,826Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to BIOGEN MA INC (1)· patent assignee history
2022–2025Based in US· patent location history
2024–2025Patents assigned to ALIVEGEN INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALIVEGEN INC | 2 | 2024–2025 |
| BIOGEN MA INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2025 |